Search

Your search keyword '"Meyding-Lamadé U"' showing total 276 results
Start Over Author "Meyding-Lamadé U"
276 results on '"Meyding-Lamadé U"'

6. Entzündliche Erkrankungen

Author

Schmutzhard, E., primary, Kaiser, R., additional, Meyding-Lamadé, U., additional, Arendt, G., additional, Nolting, T., additional, Maschke, M., additional, and Zerr, I., additional

Published
2011
Full Text
View/download PDF

7. The German trial on Aciclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis (GACHE): a multicenter, randomized, double-blind, placebo-controlled trial

Author

Meyding-Lamadé, U., primary, Jacobi, C., additional, Martinez-Torres, F., additional, Lenhard, T., additional, Kress, B., additional, Kieser, M., additional, Klose, C., additional, Einhäupl, K., additional, Bösel, J., additional, Mackert, M-B, additional, Homberg, V., additional, Koennecke, C., additional, Weißheit, G., additional, Claus, D., additional, Kieseier, B., additional, Bardutzky, J., additional, Neumann-Haefelin, T., additional, Lorenz, M. W., additional, Steinmetz, H., additional, Gerloff, C., additional, Schneider, D., additional, Grau, A., additional, Klein, M., additional, Dziewas, R., additional, Bogdahn, U., additional, Jakob, W., additional, Linker, R., additional, Fuchs, K., additional, Sander, A., additional, Luntz, S., additional, Hoppe-Tichy, T., additional, Hanley, D. F., additional, von Kummer, R., additional, and Craemer, E., additional

Published
2019
Full Text
View/download PDF

8. Infektionen

Author

Pfister, H. -W., primary, Klein, M., additional, Schmutzhard, E., additional, Meyding-Lamadé, U., additional, Sellner, J., additional, Menon, S., additional, Martinez-Torres, F., additional, Helbok, R., additional, Pfausler, B., additional, Grabowski, A., additional, and Kress, B., additional

Published
2008
Full Text
View/download PDF

21. „Mission (im)possible“

Author

Meyding-Lamadé, U., primary, Craemer, E. M., additional, Lamadé, E. K., additional, Bassa, B., additional, Enk, K., additional, Ilsen, H., additional, Jacobi, C., additional, Jost, V., additional, Lorenz, M. W., additional, Mohs, C., additional, Schwark, C., additional, Zimmerlein, B., additional, Gottschalk, T., additional, Hacke, W., additional, and Kress, B., additional

Published
2017
Full Text
View/download PDF

23. CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)—Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Author

Schmidt-Hieber, M., primary, Silling, G., additional, Schalk, E., additional, Heinz, W., additional, Panse, J., additional, Penack, O., additional, Christopeit, M., additional, Buchheidt, D., additional, Meyding-Lamadé, U., additional, Hähnel, S., additional, Wolf, H.H., additional, Ruhnke, M., additional, Schwartz, S., additional, and Maschmeyer, G., additional

Published
2016
Full Text
View/download PDF

31. Neurozystizerkose

Author

Tscherpel, C., additional, Gottschalk, A., additional, Meyding-Lamadé, U., additional, Fink, G., additional, and Burghaus, L., additional

Published
2015
Full Text
View/download PDF

32. Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)

Author

Wiendl, H., Gold, R., Berger, T., Derfuss, T., Linker, R., Mäurer, M., Aktas, O., Baum, K., Berghoff, M., Bittner, S., Chan, A., Czaplinski, A., Deisenhammer, F., Di Pauli, F., Du Pasquier, R., Enzinger, C., Fertl, E., Gass, A., Gehring, K., Gobbi, C., Goebels, N., Guger, M., Haghikia, A., Hartung, H.P., Heidenreich, F., Hoffmann, O., Kallmann, B., Kleinschnitz, C., Klotz, L., Leussink, V.I., Leutmezer, F., Limmroth, V., Lünemann, J.D., Lutterotti, A., Meuth, S.G., Meyding-Lamadé, U., Platten, M., Rieckmann, P., Schmidt, S., Tumani, H., Weber, F., Weber, M.S., Zettl, U.K., Ziemssen, T., Zipp, F., and ‘Multiple Sclerosis Therapy Consensus Group' (MSTCG)

Subjects
disease-modifying therapy, guideline, multiple sclerosis, treatment recommendation
Abstract

Multiple sclerosis is a complex, autoimmune-mediated disease of the central nervous system characterized by inflammatory demyelination and axonal/neuronal damage. The approval of various disease-modifying therapies and our increased understanding of disease mechanisms and evolution in recent years have significantly changed the prognosis and course of the disease. This update of the Multiple Sclerosis Therapy Consensus Group treatment recommendation focuses on the most important recommendations for disease-modifying therapies of multiple sclerosis in 2021. Our recommendations are based on current scientific evidence and apply to those medications approved in wide parts of Europe, particularly German-speaking countries (Germany, Austria, and Switzerland).

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results